JY231 Injection
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for JY231 Injection, covering 2024-11-05 to 2026-01-06. Get the full timeline:
Most recent: Clinical Trial Update: JY231 (JY231) Injection for the Treatment of B-cell Acute Lymphoblastic Leukemia (B-ALL) [EARLY_Phase 1]